- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
Events 146 results
Conference
May 1, 2025
Annual California Life Sciences Summit
Webinar
April 10, 2025
Combination, Personalized, and Advanced Therapy Medicinal Products
Webinar
March 25, 2025
FDA’s Office of Inspections and Investigations: A Look at FDA’s Field Operations Six Months After ORA Became OII
Speaking Engagement
February 27, 2025
Dale Giali to Speak at the 2025 Consumer Packaged Goods (CPG) Legal Forum
Speaking Engagement
February 20, 2025
Amanda Klingler and Mark Sentenac to Speak at ACI’s 2nd Annual Life Sciences AI Summit
Webinar
January 29, 2025
Summary of FDA’s New Final Guidance: Scientific Information on Unapproved Uses
Webinar
January 28, 2025
Food for Thought: What the Food & Beverage Industry Can Expect in 2025
Webinar
January 22, 2025
Year in Review for Drug and Device Advertising and Promotion
Speaking Engagement
January 6, 2025
Nikki Reeves to Speak at Inaugural Episode of FDAWatch
Speaking Engagement
December 13, 2024
Ulf Grundmann to Speak at Frankfurt School of Finance and Management’s International Healthcare Management MBA program
Speaking Engagement
December 4, 2024
Amelia Medina to Speak at EY Global Webcast
Webinar
November 28, 2024
Virtual Talk im Turm: Health Claims in Advertising Botanicals (ECJ Case C-386/23)